ASX Announcement: 5 November 2026 (Melbourne, Australia) Optiscan Imaging Ltd (ASX: OIL) Optiscan Strengthens Board with Appointment of Russell Low HIGHLIGHTS • Mr Russell Low, President and Singapore Country Head of the Clermont Group, appointed Non-Executive Director as Clermont’s nominee •...
Optiscan Strengthens Board with Appointment of Russell Low
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Optiscan Imaging Limited has announced the appointment of Russell Low as a Non-Executive Director, succeeding Sean Gardiner, effective immediately. Mr. Low, who is the President and Singapore Country Head of the Clermont Group, brings extensive healthcare leadership experience to the Board. His appointment reflects the continued support of the Clermont Group as Optiscan advances its U.S. commercial rollout. The Non-Executive Chair welcomed Mr. Low, emphasizing his governance and transformation expertise as beneficial for Optiscan's growth strategy.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- Notification of cessation of securities - OIL
- Quarterly Activities/Appendix 4C Cash Flow Report
- Optiscan Lodges U.S. FDA 510(k) Submission for InVue
- Optiscan Lodges U.S. FDA 510(k) Submission for InForm
- Change of Director's Interest Notice
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging